The Cost Effectiveness of Patient-Applied Versus Provider-Administered Intervention Strategies for the Treatment of External Genital Warts

Paul C. Langley, PhD;Stephen K. Tyring, MD, PhD;Michael H. Smith, MS;

Publication

Article

January 1, 1999

The American Journal of Managed Care

January 1999

Volume5

Issue 1

The Cost Effectiveness of Patient-Applied Versus Provider-Administered Intervention Strategies for the Treatment of External Genital Warts

Author(s):

Paul C. Langley, PhD,Stephen K. Tyring, MD, PhD

Download PDF: The Cost Effectiveness of Patient-Applied Versus Provider-Administered Intervention Strategies for the Treatment of External Genital Warts

Articles in this issue

Safety and Efficacy of Metformin in a Restricted Formulary

The Cost Effectiveness of Patient-Applied Versus Provider-Administered Intervention Strategies for the Treatment of External Genital Warts

Medical Nutrition Therapy: A Powerful Tool in Disease Management

Maintenance Drug Therapy of Chronic Obstructive Pulmonary Disease

Correspondence regarding, "Compliance with Antihypertensive Therapy: Raising the Bar of Expectations"

Obstacles to Early Discharge After Cardiac Surgery

A Community Hospital-Based Congestive Heart Failure Program: Impact on Length of Stay, Admission and Readmission Rates, and Cost

Integrating Healthcare for Older Populations

Antibiotic Therapy of Helicobacter pylori Infection Reduces Healthcare Expenditures Related to Duodenal Ulcer

Related Content

May 16th 2025

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

Ofer Kobo, MD Martin K. Rutter, MD Shivani Misra, PhD Erin D. Michos, MD, MHS Phyo K. Myint, MD Ariel Roguin, MD, PhD Louise Y. Sun, MD Mamas A. Mamas, MD

This study validates the Predicting Risk of CVD Events (PREVENT) score across diverse racial and ethnic populations, highlighting its effectiveness in predicting cardiovascular risk and mortality, regardless of race or ethnicity.

May 15th 2025

Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening Benefits

Portia J. Zaire, PhD, RN A. Mark Fendrick, MD Jacob E. Kurlander, MD, MS Archana Radhakrishnan, MD, MHS

Investing in patient navigation and clinician incentives ensures colorectal cancer screening completion, improves early detection, reduces disparities, achieves cost savings, and advances population health for all stakeholders.

May 14th 2025

Digital Health Implementation Among Older Adults: Health Technology Navigators’ Perspectives

Katarina Wang, BS Ann Marie Hernandez, MD, MPH Veronica Penate, BS Anshu Abhat, MD, MPH Alejandra Casillas, MD, MSHS

Health technology navigators share perspectives on barriers to and facilitators of digital health access for older, linguistically diverse patients in a Los Angeles safety-net system.

May 13th 2025

Using Data Exchange to Improve Quality Reporting, Target Outreach, and Reduce Cost

Barbara Rubino, MD Chelsea Hart-Connor, MA Todd A. May, MD

Covered California and Health Net’s novel data exchange initiative significantly improved quality measurement and potentially reduced costs by more than $640,000.

May 12th 2025

Effects of Maryland’s All-Payer Model on Elective Joint Replacement Surgery

Meiling Ying, PhD Addison Shay, MS John M. Hollingsworth, MD, MS Vahakn B. Shahinian, MD Richard A. Hirth, PhD Brent K. Hollenbeck, MD, MS

The Maryland All-Payer Model was associated with an increase in population-based rates of elective major joint replacements, with a more pronounced effect observed in Maryland-only hospitals.

May 9th 2025

Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare

Kenneth Cohen, MD Boris Vabson, PhD Jennifer Podulka, MPAff Omid Ameli, MD, DrPH Kierstin Catlett, PhD Nathan Smith, PhD Megan S. Jarvis, MS Jane Sullivan, MPH Caroline Goldzweig, MD, MSHS Susan Dentzer, MS

Physician groups under 2-sided risk–based Medicare Advantage provide care associated with higher quality and efficiency compared with care by these same groups under fee-for-service Medicare.

Related Content

May 16th 2025

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

Ofer Kobo, MD Martin K. Rutter, MD Shivani Misra, PhD Erin D. Michos, MD, MHS Phyo K. Myint, MD Ariel Roguin, MD, PhD Louise Y. Sun, MD Mamas A. Mamas, MD

May 15th 2025

Navigation and Clinician Payment Investments Enhance Colorectal Cancer Screening Benefits

Portia J. Zaire, PhD, RN A. Mark Fendrick, MD Jacob E. Kurlander, MD, MS Archana Radhakrishnan, MD, MHS

May 14th 2025

Digital Health Implementation Among Older Adults: Health Technology Navigators’ Perspectives

Katarina Wang, BS Ann Marie Hernandez, MD, MPH Veronica Penate, BS Anshu Abhat, MD, MPH Alejandra Casillas, MD, MSHS

Health technology navigators share perspectives on barriers to and facilitators of digital health access for older, linguistically diverse patients in a Los Angeles safety-net system.

May 13th 2025

Using Data Exchange to Improve Quality Reporting, Target Outreach, and Reduce Cost

Barbara Rubino, MD Chelsea Hart-Connor, MA Todd A. May, MD

Covered California and Health Net’s novel data exchange initiative significantly improved quality measurement and potentially reduced costs by more than $640,000.

May 12th 2025

Effects of Maryland’s All-Payer Model on Elective Joint Replacement Surgery

Meiling Ying, PhD Addison Shay, MS John M. Hollingsworth, MD, MS Vahakn B. Shahinian, MD Richard A. Hirth, PhD Brent K. Hollenbeck, MD, MS

The Maryland All-Payer Model was associated with an increase in population-based rates of elective major joint replacements, with a more pronounced effect observed in Maryland-only hospitals.

May 9th 2025

Health Outcomes Under Full-Risk Medicare Advantage vs Traditional Medicare

Physician groups under 2-sided risk–based Medicare Advantage provide care associated with higher quality and efficiency compared with care by these same groups under fee-for-service Medicare.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions